#United States #New York #Class Action #Investor Rights #Boston Scientific

Bronstein, Gewirtz & Grossman LLC Takes Action on Behalf of Boston Scientific Investors

In a significant move, Bronstein, Gewirtz & Grossman LLC, a well-respected law firm specializing in investor rights, has announced a class action lawsuit against Boston Scientific Corporation (NYSE: BSX). The firm urges all individuals or entities that acquired Boston Scientific securities between July 23, 2025, and February 3, 2026, to participate in this legal action. This period, referred to as the 'Class Period', is crucial for those who believe they may have suffered financial harm due to the company's practices that allegedly violated federal securities laws.

Allegations Against Boston Scientific

The foundation of this lawsuit rests on several key allegations. Primarily, the complaint claims that Boston Scientific made several materially false and misleading statements about its business operations and growth prospects. Specifically, it is alleged that:

• - The company misrepresented the sustainability of its growth, particularly in the U.S. electrophysiology (EP) segment for fiscal year 2025.
• - Confidence expressed by the company regarding the growth trajectory and competitive standing of the U.S. EP division was not backed by sufficient evidence or rational basis.
• - Evidence points to declining procedure volumes, intensifying competition, and regulatory challenges adversely impacting the U.S. EP segment—facts that were allegedly concealed from investors.
• - Management was reportedly aware that the U.S. EP segment's anticipated growth was reaching an inflection point sooner than previously expected, yet continued to communicate positive growth expectations to investors and analysts.

Due to these factors, statements made by Boston Scientific regarding the robustness of their growth in key product segments, alongside optimistic full-year guidance revisions, have been called into question.

Crucial Next Steps for Affected Investors

For Boston Scientific investors who might have sustained losses during this class period, joining this lawsuit could be pivotal. Interested parties are encouraged to visit the firm’s website at bgandg.com/BSX for further details about the case and to review a copy of the complaint. Additionally, potential plaintiffs have until May 4, 2026, to request the court to appoint them as lead plaintiff, although this does not hinder their ability to share in any eventual recovery from the lawsuit.

No Financial Risk to Investors

Bronstein, Gewirtz & Grossman LLC operates on a contingency fee basis, meaning that they will cover all legal expenses upfront. Investors will only be required to pay attorneys' fees and associated costs if the case results in a financial recovery. This approach provides an accessible avenue for investors to seek recompense without the stress of immediate out-of-pocket costs.

Why Choose Bronstein, Gewirtz & Grossman LLC?

Choosing to represent investors in class actions, Bronstein, Gewirtz & Grossman LLC has earned a reputation for handling securities fraud cases effectively. The firm’s founding partner, Peretz Bronstein, emphasizes their commitment to restoring investor capital and maintaining corporate accountability, which is vital for preserving the integrity of financial markets. The firm has successfully recovered hundreds of millions of dollars for investors across the nation. More information can be found at www.bgandg.com.

Stay Updated

For ongoing updates regarding this class action lawsuit and other investor-related matters, interested parties are encouraged to follow Bronstein, Gewirtz & Grossman LLC on various social media platforms, including LinkedIn, X, Facebook, and Instagram. It is critical for investors to remain informed about their rights and any developments that might affect their investments.

Contact Information

For further inquiries, investors can reach out to Bronstein, Gewirtz & Grossman LLC's representatives, including Peretz Bronstein, Esq., or Client Relations Manager Nathan Miller, at 917-590-0911 or via email.

Attorney advertising notice: Past results do not guarantee similar future outcomes, and this communication is intended to provide information about the law firm's services and the current lawsuit.